FormulaFolio Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,812
Closed -$279K 395
2019
Q3
$279K Sell
2,812
-73
-3% -$6.94K 0.01% 295
2019
Q2
$267K Buy
2,885
+136
+5% +$12.9K 0.01% 280
2019
Q1
$259K Sell
2,749
-740
-21% -$64.7K 0.01% 284
2018
Q4
$312K Hold
3,489
0.01% 263
2018
Q3
$312K Buy
3,489
+822
+31% +$72.6K 0.01% 263
2018
Q2
$212K Buy
2,667
+73
+3% +$6.06K 0.01% 286
2018
Q1
$231K Buy
2,594
+131
+5% +$12.6K 0.01% 247
2017
Q4
$257K Sell
2,463
-343
-12% -$38.7K 0.02% 229
2017
Q3
$409K Buy
2,806
+313
+13% +$42.6K 0.03% 156
2017
Q2
$324K Sell
2,493
-525
-17% -$64.3K 0.03% 165
2017
Q1
$376K Sell
3,018
-213
-7% -$25.5K 0.04% 135
2016
Q4
$374K Buy
3,231
+708
+28% +$78.8K 0.05% 121
2016
Q3
$264K Buy
2,523
+29
+1% +$3.14K 0.04% 116
2016
Q2
$246K Buy
2,494
+48
+2% +$4.96K 0.04% 108
2016
Q1
$245K Buy
2,446
+46
+2% +$4.74K 0.04% 111
2015
Q4
$287K Hold
2,400
0.07% 82
2015
Q3
$260K Sell
2,400
-300
-11% -$37.2K 0.08% 62
2015
Q2
$312K Buy
+2,700
New +$309K 0.09% 76

Other funds holding CELG

FormulaFolio Investments's CELG Position: Q4 2019 in Review

FormulaFolio Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,812 shares — an estimated $279K sold.

FormulaFolio Investments first reported a position in CELG in Q2 2015 and held it in 18 quarters. The position peaked at $409K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • FormulaFolio Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • FormulaFolio Investments sold 2,812 Celgene Corp shares in Q4 2019, an estimated $279K.
  • FormulaFolio Investments first reported a position in Celgene Corp in Q2 2015 and held it in 18 quarters.
  • FormulaFolio Investments's Celgene Corp position peaked at $409K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on FormulaFolio Investments's 13F filing for Q4 2019, filed 15 Jan 2020.